Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes: Low ACE2 glycosilation and Cat-L activity reduce COVID-19.
Giovanni BertoldiVerdiana RavarottoLuca SgarabottoPaul A DavisLaura GobbiLorenzo Arcangelo CalòPublished in: Journal of internal medicine (2021)
None This article is protected by copyright. All rights reserved.